SciSparc Receives Final Approval to Commence its Phase IIb C

SciSparc Receives Final Approval to Commence its Phase IIb Clinical Trial for SCI-110 to treat Tourette Syndrome

SciSparc Receives Final Approval to Commence its Phase IIb Clinical Trial for SCI-110 to treat Tourette Syndrome
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Connecticut , United States , Yale University , Germany , Tel Aviv , Israel , Hannover , Niedersachsen , German , Tanya Gurevich , Oz Adler , Michaelh Bloch , Head Of Movement Disorders Unit , German Federal Institute For Drugs , Nasdaq , Company Or Scisparc , Department Of Psychiatry , Drug Administration , Hannover Medical School , Department Of Neurology , Scisparc Ltd , Company Phase Iib Clinical Trial , Yale School Of Medicine , Yale Child Study Center , Tel Aviv Sourasky Medical Center , Exchange Commission , Clinical Trial , Tourette Syndrome , Movement Disorders Unit , Yale School , United States Food , German Federal Institute , Chief Executive Officer , Yale Global Tic Severity Scale , Looking Statements , Private Securities Litigation Reform Act , Annual Report ,